Improved Alzheimer's Disease Detection by MRI Using Multimodal Machine Learning Algorithms

Gopi Battineni1, Mohmmad Amran Hossain1, Nalini Chintalapudi1

  • 1Telemedicine and Telepharmacy Centre, School of Medicinal and Health Products Sciences, University of Camerino, 62032 Camerino, Italy.

Insights

This study uses machine learning and MRI scans to accurately diagnose Alzheimer's disease (AD) in adults. The gradient boosting algorithm achieved 97.58% accuracy, improving upon traditional diagnostic methods.

Area of Science:

  • Neurology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Alzheimer's disease (AD) is the most common form of adult-onset dementia.
  • Traditional AD diagnosis relies on clinical criteria with limited accuracy (85%) and requires post-mortem confirmation.
  • Advancements in Magnetic Resonance Imaging (MRI) and machine learning (ML) offer potential for earlier and more accurate AD detection.

Purpose of the Study:

  • To develop and evaluate a machine learning framework for classifying Alzheimer's disease (AD) versus non-AD subjects.
  • To leverage longitudinal brain MRI features for improved diagnostic accuracy.
  • To compare the performance of six supervised learning classifiers for AD detection.

Main Methods:

  • A supervised learning framework was implemented using longitudinal brain MRI data.
  • Six distinct supervised classification algorithms were employed for AD subject categorization.
  • Patient demographic information and pre-existing conditions were considered to enhance classifier performance.

Main Results:

  • The gradient boosting algorithm demonstrated superior performance among the evaluated models.
  • The proposed framework achieved a high accuracy of 97.58% in classifying AD subjects.
  • The study highlights the potential of ML applied to MRI for precise AD diagnosis.

Conclusions:

  • Machine learning models, particularly gradient boosting, show significant promise for accurate and early Alzheimer's disease diagnosis using MRI.
  • Integrating demographic and clinical data can further enhance the predictive power of ML classifiers for AD.
  • This approach offers a non-invasive method to aid in the definitive diagnosis of AD, potentially improving patient management.